Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Redsense Medical AB announces approval by University Health Network in Toronto, Canada , to conduct a follow up study of the Redsense Clamp prototype

Redsense Medical AB has previously submitted a renewal application to conduct a follow up study on a prototype of the Company’s accessory product Redsense Clamp, which enables automatic stop of blood flow independent of the dialysis machine in use. This application has now been approved by the Research Ethics Board of the University Health Network, allowing the Company to proceed with the follow up study in Toronto. Redsense has previously conducted a usability study on Redsense Clamp together with the UHS. In October 2018, Redsense announced the completion of this study, where Canadian

Swedavia’s traffic statistics for July 2020: Passenger volume down 87 per cent

During July, 486,000 passengers flew via Swedavia’s ten airports, a decrease of 87 per cent compared to 3.8 million passengers during the same month last year. The aviation market shows new signs of recovery, but the effects of the Covid-19 pandemic have continued to have a strong negative impact on the demand for flights. As a result, the market outlook remains uncertain.Of the 486,000 passengers in July, 307,000 were international passengers, which is a 90 per cent decrease from last year. Domestic travel decreased to a somewhat lesser extent, with a downturn of 79 per cent in July,

First patient in treatment in RhoVac's clinical phase IIb study in the USA

RhoVac AB ("RhoVac") announces today, August 10th 2020, that the first patient in the USA is included in the company's clinical phase IIb study in prostate cancer, a study entitled RhoVac-002 ("BRaVac").The first patient in the USA is included in RhoVac’s clinical phase IIb study, called BRaVac. The first US clinic to include a patient in the study was Carolina Urologic Research Center. BraVac is a randomized, placebo controlled and double-blind study, with the primary objective of evaluating if treatment with the drug candidate RV001 can prevent or limit the development of advanced

Shawbrook Bank “cautiously optimistic” as it Publishes Half Year Report for 2020

· Financial performance impacted by the pandemic · Expected credit loss (ECL) charges of £45.8 million recognised on loans and advances to customers · Profit before tax (PBT) was impacted by the adverse effects of COVID-19 and the subsequent provisions set aside, reducing by 89% to £5.9 million · Customer deposits rose by 25% to £7.6 billion while capital remained strong with a CET1 ratio of 12.3% · A total of 15.9k payment holidays granted across the Group · The specialist bank continued to operate effectively through COVID-19 · 98% of employees moved to remote

Corporate apartments and ultra-modern offices for Umami Park

13 minutes from Stockholm City in Umami Park, Sundbyberg, 85 newly constructed, premium apartments for companies are now ready through the housing concept ‘Umami easy living’ –furnished or unfurnished corporate apartments that Wallenstam will let under its own management to companies as long-term accommodation or apartments for overnight stays. Meanwhile, the area’s first office space is now ready in the so-called Central block after an extensive renovation with sustainability in focus.“Based on Umami Park’s attractive location with proximity and really good communications to the city,

Adverty enters into agreement and completes integration with SuperAwesome to enable kid-safe advertising

Adverty AB (publ) has signed an agreement with the leading kidtech platform SuperAwesome, to allow compliant, kid-safe ads to be displayed in relevant mobile games using Adverty’s in-game ad technology. The completed platform integration allows for frictionless access between SuperAwesome’s connected advertisers and Adverty’s game publishers. The partnership is expected to generate significant revenues from 2021 onwards.Adverty, the leading in-game platform for advertisers, agencies and content creators, announces a new partnership with the leading kidtech platform SuperAwesome, to enable

Invitation to the presentation of Bactiguard’s interim report on August 13, 2020

Bactiguard Holding AB (publ) publishes the interim report for the second quarter on Thursday August 13, 2020 at 7:30 CET.In connection with this, a webcast for investors, analysts and media will be held at 10:00 CET on August 13. CEO Cecilia Edström will present the interim report and answer questions. Bactiguard's new CFO Gabriella Caracciolo will also participate. The report and a presentation for the webcast will be available at Bactiguard’s website www.bactiguard.com.  To participate in the webcast, please use this link:https://tv.streamfabriken.com/bactiguard-q2-2020 To

Ideagen Announces £15.6m Acquisition of Key Competitor Qualsys

Leading international provider of software for the audit, risk and compliance market, Ideagen Plc (AIM:IDEA), has today announced the acquisition of key competitor, Qualsys, for £15.6m. Qualsys is an EQMS (Electronic Quality Management Software) company based in Sheffield. The business was started in 1995 by Mike Pound and Mike Bendall and now employs more than 50 people. Its products are used by more than 500,000 people in more than 120 countries. Qualsys has blue chip customers, such as Diageo, Unilever, Honeywell and BT, across a range of industries, including pharmaceutical,

Orexo receives paragraph IV Notice Letter for ZUBSOLV® in the US

Uppsala, Sweden – August 10, 2020 – Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY), today announces it has received a “paragraph IV” patent certification notice from Sun Pharmaceutical Industries Limited (“Sun”). The Notice Letter advises Orexo of Sun’s filing of an Abbreviated New Drug Application (“ANDA”) with the US Food and Drug Administration (FDA) seeking approval of generic versions of ZUBSOLV® before the expiration of Orexo’s patents listed in the Orange Book. Orexo currently has five patents listed in the Orange Book (US Patent Nos. 8,470,361; 8,658,198; 8,940,330; 9,259,421 and 9,439,

Revenio Group Corporation: Managers' Transactions

Revenio Group Corporation, Stock Exchange Release, August 10, 2020 at 9.00Revenio Group Corporation - Managers' Transactions____________________________________________ Person subject to the notification requirementName: Pulkkinen RobinPosition: Chief Financial Officer(X) Legal personIssuer: Revenio Group CorporationLEI: 743700I27E0FWSXLKK04 Notification type: INITIAL NOTIFICATIONReference number: 743700I27E0FWSXLKK04_20200809200059_2____________________________________________ Transaction date: 2020-08-07Venue: FIRST NORTH FINLAND (FNFI)Instrument type:

Borr Drilling Limited Announces Appointment of Patrick Schorn as CEO

Borr Drilling Limited (the “Company”) (NYSE: “BORR”, OSE: “BDRILL”) is pleased to announce the appointment of Patrick Schorn as its new Chief Executive Officer with effect from 8 September 2020.  Mr. Schorn will succeed Svend Anton Maier who will remain with the Company as Special Advisor to the Chief Executive Officer.  Mr Schorn has been a Director of the Company since January 2018. Paal Kibsgaard, Chairman of the Board, commented: “We are pleased to announce Patrick as the new Chief Executive Officer of Borr Drilling. His extensive industry experience and his tenure as a Director

Polygon AB (publ) - Interim report 1 January - 30 June 2020

Great performance in an exceptional quarterSECOND QUARTER 2020 · Sales grew 8.6% to EUR 171.3 million, organic growth amounted to 6.3% and acquired growth contributed 3.8%. · Adjusted EBITA amounted to EUR 9.5 million, an increase of 15% compared to last year. · Operating profit amounted to EUR 8.4 million (5.4). · Polygon has signed agreements to acquire Hiotlabs in Sweden, Aretech and Hydrotech in France, and UTG in Luxembourg. · For the second quarter 2020, the impact of the covid-19 outbreak has been limited for the Group. JANUARY – JUne  2020 · Sales grew 12.7%

Tokmanni will open a new store in Kirkonkylä in Nurmijärvi

Tokmanni        Press release        10 August 2020 at 8:30   Tokmanni, the largest general discount retailer chain in Finland, has concluded an agreement with the Lehto Group on the leasing of premises for a new store in the Kirkonkylä area in Nurmijärvi, at the address Toreenintie 2a, 01900 Nurmijärvi. Tokmanni already has a store in the Klaukkala area in Nurmijärvi that will be unaffected by this development. The opening of the new Tokmanni in Nurmijärvi will be celebrated in October–November 2021.Tokmanni in Nurmijärvi will offer a wide and attractive assortment of beauty,

Nordic Nanovector Appoints Dr Christine Wilkinson Blanc as Chief Medical Officer

Oslo, Norway, 10 August 2020 Nordic Nanovector ASA (OSE: NANO) announces that Dr Christine Wilkinson Blanc has been appointed Chief Medical Officer with immediate effect. Dr Wilkinson Blanc is a seasoned pharmaceutical physician with broad experience in oncology and haematology with both large pharmaceutical and emerging biotechnology companies. She has over 25 years of experience in the pharmaceutical industry and has led multiple clinical studies across all phases for a wide range of indications. Dr Wilkinson Blanc joins us through her relationship with Weatherden, a specialist

Scottish solutions experts launch innovation to help pubs comply with new laws

A SCOTTISH solutions company is launching a new system to help pubs, restaurants and cafes keep staff and customers safe in light of new laws across the nation.First Minister Nicola Sturgeon announced that from Friday (August 14) it will be mandatory for the hospitality sector to collect customer details for the Scottish Government's Test and Protect programme in the wake of a coronavirus outbreak in Aberdeen.Scottish solutions experts Eco, who received national acclaim for the way they responded to the pandemic to help care homes and other businesses, is launching a new contactless

Leading Edge Materials Announces Closing of C$3,520,000 Non-Brokered Private Placement and New Control Person

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER, OR A SOLICITATION OF ANY OFFER, TO BUY OR SUBSCRIBE FOR ANY SECURITIES IN LEADING EDGE MATERIALS IN ANY JURISDICTION.VANCOUVER, August 7, 2020 /CNW/ - Leading Edge Materials Corp. (“Leading Edge Materials” or the “Company”) (TSXV: LEM) (Nasdaq First North: LEMSE) (OTCQB: LEMIF)

#20-274 Delisting of certain Derivatives from NGM

Certain derivatives will be delisted from NGM.For more details see attached files. For further information concerning this NGM notice please contact: Listing department on +46 8 566 390 20 or at listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

#20-273 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

Asetek Presents Second Quarter 2020 Results on Wednesday, 12 August

Asetek will release its financial results for the second quarter of 2020 on Wednesday, 12 August at 10:30 AM CEST. CEO André Sloth Eriksen and CFO Peter Dam Madsen will present the Company's results at 11:30 AM CEST and invites investors, analysts and media to join the presentation. The presentation is expected to last up to one hour, including Q&A, and can be followed via live webcast or conference call. Webcast - audio and slide presentation: Please join the results webcast via the following link: https://edge.media-server.com/mmc/p/wdjy2yyg Conference call - audio only:

News conference on Kojamo’s Half-Year Report for January–June 2020 on 20 August 2020

Kojamo Plc Press Release, 7 August 2020 at 4:15 p.m. EESTNews conference on Kojamo’s Half-Year Report for January–June 2020 on 20 August 2020 Kojamo plc’s Half-Year Report for January–June 2020 will be published on Thursday, 20 August 2020 at approximately 8:00 a.m. EEST. News conference and webcast Kojamo will hold a news conference for institutional investors, analysts and media on 20 August 2020 at 10:00 a.m. at its headquarters at Mannerheimintie 168A, Helsinki, Finland. The event will be hosted by Kojamo’s CEO Jani Nieminen and CFO Erik Hjelt, and it will be held in English.

Observe Medical signs updated distribution agreement for Sippi® in Italy

Oslo 7 August 2020 – Observe Medical ASA (OSE: OBSERV), today announces it has entered into an updated distribution agreement and strengthened partnership with SIM Italia S.r.l. for the launch of Sippi® in the Italian market. “We are pleased to announce our strengthened partnership with SIM Italia and the signing of an updated distribution agreement for the important Italian market. SIM Italia is a well-established and professional partner, highly committed to launch Sippi® in Italy together with us, to the benefit of the Italian healthcare system and patients,” says Björn Larsson, CEO

Revenio Group Corporation: Managers' Transactions

Revenio Group Corporation, Stock Exchange Release, August 7, 2020 at 15.50Revenio Group Corporation - Managers' Transactions____________________________________________ Person subject to the notification requirementName: Isomäki AriPosition: Other senior manager(X) Legal personIssuer: Revenio Group CorporationLEI: 743700I27E0FWSXLKK04 Notification type: INITIAL NOTIFICATIONReference number: 743700I27E0FWSXLKK04_20200807153946_2____________________________________________ Transaction date: 2020-08-06Venue: FIRST NORTH FINLAND (FNFI)Instrument type: FINANCIAL

Notification in accordance with the Finnish Securities Market Act Chapter 9 § 5: BlackRock, Inc.’s holding in Wärtsilä Corporation

Wärtsilä Corporation, Stock exchange release, 7 August 2020 at 3.45 pm EESTNotification in accordance with the Finnish Securities Market Act Chapter 9 § 5: BlackRock, Inc.’s holding in Wärtsilä Corporation   BlackRock, Inc. has informed Wärtsilä Corporation that it has crossed above the 5% disclosure limit on shares and voting rights on 6 August 2020. Total position of BlackRock, Inc. and its funds subject to the notification: % of % of shares Total of Total number of shares shares and voting both in % and voting rights of

There are no items matching the current filter
There are no more items matching the current filter
Back to top